Soumyadeep Dey

Designation:
Department:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH
University:
Country:
USA
Journal Associated: Archives of Renal Diseases and Management Biography:

Research Interest: Erythropoietin (EPO) is approved by FDA for administration to chronic renal disease patients and cancer patients to treat anemia, but my active area of research is to understand how EPO affects non-hematopoietic physiological response. My specific research interest is focussed on how EPO affects inflammation in the brain and periphery and regulates metabolic homeostasis

Global Views

Case Reports

Peertechz Tweets